Skip to main content

Table 3 HPV-capsid antibodies in HIV-positive (+) or HIV-negative (-) men with anogenital carcinoma

From: High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study

VLP-type

6

11

16

18

31

cumulative

cumulative

      

low risk (6, 11)

high risk (16, 18, 31)

HIV + (n = 3)

3/3

2/3

3/3

2/3

2/3

3/3

3/3

HIV - (n = 7)

0/7

0/7

1/7

0/7

1/7

0/7

2/7